Oncotype DX® tests
The Oncotype DX Breast Recurrence Score® test
The Oncotype DX Breast Recurrence Score test provides a genomic-based, comprehensive, individualized risk assessment for early-stage invasive breast cancer in adjuvant and neoadjuvant settings.
READ MORE
The Oncotype DX® Genomic Prostate Score™ assay
The Oncotype DX Genomic Prostate Score assay is the only genomic assay designed for men with clinically low-risk or favorable intermediate-risk cancer to help make treatment decisions at the time of diagnosis.
READ MORE
The Oncotype DX® Colon Recurrence Score™ assay
The Oncotype DX Colon Recurrence Score assay is clinically validated to quantify the risk of recurrence of patients with anatomic stage II
READ MORE